Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Idioma
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Zhongguo Dang Dai Er Ke Za Zhi ; 16(3): 230-3, 2014 Mar.
Artigo em Zh | MEDLINE | ID: mdl-24661511

RESUMO

OBJECTIVE: To evaluate the clinical effect of proton pump inhibitor-based triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori (Hp) infection among children in terms of Hp eradication rate and incidence of adverse events. METHODS: A prospective randomised controlled study was conducted on 240 children with a confirmed diagnosis of Hp infection. These patients were randomized into triple therapy (n=120) and probiotics groups (n=120). The triple therapy group received amoxicillin [40 mg/(kg·d), Tid], clarithromycin [15 mg/(kg·d), Bid] and omeprazole [0.7-0.8 mg/(kg·d), Qd], while the probiotics group received Saccharomyces boulardii (250 mg, Bid) in addition to triple therapy. The course of treatment was 14 days in both groups. The adverse events in subjects were recorded by their parents during treatment. Hp eradiation was evaluated by (13)C breath test at 4 weeks after treatment, and the eradication rate and incidence of adverse events were compared between the two groups. RESULTS: The Hp eradication rates were 75.8% (91/120) in the triple therapy group and 85% (102/120) in the probiotics group (P>0.05). Compared with the triple therapy group, the probiotics group had nonsignificantly lower incidence of nausea, vomiting, and abdominal pain (P>0.05) and significantly lower incidence of stomatitis, constipation and diarrhea (P<0.05). CONCLUSIONS: Triple therapy combined with Saccharomyces boulardii cannot significantly increase Hp eradication rate, but can significantly reduce the incidence of stomatitis, constipation, and diarrhea during treatment.


Assuntos
Infecções por Helicobacter/terapia , Helicobacter pylori , Probióticos/administração & dosagem , Saccharomyces , Amoxicilina/administração & dosagem , Criança , Pré-Escolar , Claritromicina/administração & dosagem , Terapia Combinada , Quimioterapia Combinada , Feminino , Humanos , Masculino , Omeprazol/administração & dosagem , Estudos Prospectivos
2.
Zhongguo Dang Dai Er Ke Za Zhi ; 15(7): 546-9, 2013 Jul.
Artigo em Zh | MEDLINE | ID: mdl-23866276

RESUMO

OBJECTIVE: To investigate the diagnostic value and safety of single-balloon electronic enteroscopy in children with small intestinal bleeding. METHODS: Seventy children with clinically suspected small intestinal bleeding, including 38 males and 32 females aged 4-13 years, underwent single-balloon enteroscopy under general anesthesia. Twenty-six cases underwent the procedure through the mouth, 32 cases through the anus, and 12 cases through both. RESULTS: Of the 70 children, 58 (83%) had small bowel disease according to the single-balloon enteroscopy results, including 24 cases of non-specific inflammation, 12 cases of allergic purpura, 8 cases of Crohn's disease, 8 cases of Meckel's diverticulum, and 6 cases of Peutz-Jeghers syndrome. CONCLUSIONS: Single-balloon enteroscopy is a safe, effective means for the diagnosis of small intestinal bleeding among children.


Assuntos
Endoscopia Gastrointestinal/métodos , Hemorragia Gastrointestinal/diagnóstico , Intestino Delgado/patologia , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA